Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Genetic cross-disorder analysis in psychiatry: from methodology to clinical utility.

Schijven D, Veldink JH, Luykx JJ.

Br J Psychiatry. 2019 Apr 1:1-4. doi: 10.1192/bjp.2019.72. [Epub ahead of print]

PMID:
30931869
2.

The effect of genetic vulnerability and military deployment on the development of post-traumatic stress disorder and depressive symptoms.

Schür RR, Schijven D, Boks MP, Rutten BPF, Stein MB, Veldink JH, Joëls M, Geuze E, Vermetten E, Luykx JJ, Vinkers CH.

Eur Neuropsychopharmacol. 2019 Mar;29(3):405-415. doi: 10.1016/j.euroneuro.2018.12.009. Epub 2019 Feb 14.

PMID:
30773389
3.

Constitutive Serotonin Transporter Reduction Resembles Maternal Separation with Regard to Stress-Related Gene Expression.

Comasco E, Schijven D, de Maeyer H, Vrettou M, Nylander I, Sundström-Poromaa I, Olivier JDA.

ACS Chem Neurosci. 2019 Jul 17;10(7):3132-3142. doi: 10.1021/acschemneuro.8b00595. Epub 2019 Jan 23.

PMID:
30614673
4.

The role of genetic variation of human metabolism for BMI, mental traits and mental disorders.

Hebebrand J, Peters T, Schijven D, Hebebrand M, Grasemann C, Winkler TW, Heid IM, Antel J, Föcker M, Tegeler L, Brauner L, Adan RAH, Luykx JJ, Correll CU, König IR, Hinney A, Libuda L.

Mol Metab. 2018 Jun;12:1-11. doi: 10.1016/j.molmet.2018.03.015. Epub 2018 Apr 3.

5.

Comprehensive pathway analyses of schizophrenia risk loci point to dysfunctional postsynaptic signaling.

Schijven D, Kofink D, Tragante V, Verkerke M, Pulit SL, Kahn RS, Veldink JH, Vinkers CH, Boks MP, Luykx JJ.

Schizophr Res. 2018 Sep;199:195-202. doi: 10.1016/j.schres.2018.03.032. Epub 2018 Apr 11.

PMID:
29653892
6.

Genetic correlation between amyotrophic lateral sclerosis and schizophrenia.

McLaughlin RL, Schijven D, van Rheenen W, van Eijk KR, O'Brien M, Kahn RS, Ophoff RA, Goris A, Bradley DG, Al-Chalabi A, van den Berg LH, Luykx JJ, Hardiman O, Veldink JH; Project MinE GWAS Consortium; Schizophrenia Working Group of the Psychiatric Genomics Consortium.

Nat Commun. 2017 Mar 21;8:14774. doi: 10.1038/ncomms14774.

7.

MID-PREGNANCY CORTICOTROPIN-RELEASING HORMONE LEVELS IN ASSOCIATION WITH POSTPARTUM DEPRESSIVE SYMPTOMS.

Iliadis SI, Sylvén S, Hellgren C, Olivier JD, Schijven D, Comasco E, Chrousos GP, Sundström Poromaa I, Skalkidou A.

Depress Anxiety. 2016 Nov;33(11):1023-1030. doi: 10.1002/da.22529. Epub 2016 May 27.

PMID:
27232288
8.

Treatment with serotonin reuptake inhibitors during pregnancy is associated with elevated corticotropin-releasing hormone levels.

Hannerfors AK, Hellgren C, Schijven D, Iliadis SI, Comasco E, Skalkidou A, Olivier JD, Sundström-Poromaa I.

Psychoneuroendocrinology. 2015 Aug;58:104-13. doi: 10.1016/j.psyneuen.2015.04.009. Epub 2015 Apr 21.

PMID:
25978816
9.

Gene Expression in Placentas From Nondiabetic Women Giving Birth to Large for Gestational Age Infants.

Ahlsson F, Åkerud H, Schijven D, Olivier J, Sundström-Poromaa I.

Reprod Sci. 2015 Oct;22(10):1281-8. doi: 10.1177/1933719115578928. Epub 2015 Mar 30.

PMID:
25824011
10.

Serotonin 1A receptors and sexual behavior in a genetic model of depression.

Schijven D, Sousa VC, Roelofs J, Olivier B, Olivier JD.

Pharmacol Biochem Behav. 2014 Jun;121:82-7. doi: 10.1016/j.pbb.2013.12.012. Epub 2013 Dec 15.

PMID:
24345571

Supplemental Content

Loading ...
Support Center